Worst performer was last week's Share of the Week CWR:Ceres Power, which dropped 11% after lackluster interims and likely profit taking following the 44% rise last week.
TRX:Tissue Regenix had a 2nd big drop in a row, falling 9% to go 85% down.
PBX:Probiotix Health dropped 7% and will likely continue to drift until there is some news.
AMP:Ampeak Energy fell 5% after their interim results to go 74% down.
TLOU:Tlou Energy continue to yo-yo and dropped 5% this week to go 36% down.
CAPD:Capital rose 5% and it was a lot more than that in mid-week, allowing me to sell my SIPP holding. My remaining dealing account holding is 10% down and hopefully I can sell it soon.
RIO:Rio Tinto went up 5% but still seems to be lagging the other miners. My holding is only 4% down and I'm tempted to buy more when my pension transfer comes in a couple of weeks.
FDM:FDM Group recovered 6% of their recent losses but are still 60% down.
BOKU:Boku climbed an impressive 7% and are now 13% in profit.
GGP:Greatland Resources went up 10% and are 25% in profit.
IES:Invinity Energy went up 10% after revealing quite a few projects to deliver their batteries may be eligible for grant aid.
CORE:Solidcore Resources finally seems to be catching up with the other gold miners, and climbed 15%, but my holding is still 76% down.
Share of the Week is OPTI:Optibiotix which went up 17%, helped by the CEO buying a load of shares and possibly in anticipation of Sweetbiotix news in the next few weeks.
Here's the ISA and shares portfolio after week 9 of year 11.
| Weekly Change | |||
| Cash | £73.08 | +£0 | |
| Portfolio cost | £115,878.07 | +£0 | |
| Portfolio sell value (bid price-commission) | £37,945.50 | (-67.3%) | +£1,691.14 |
| Potential profits | £128.60 | +£74.25 | |
| Yr 11 Dividends | £0 | +£0 | |
| Yr 11 Interest | £0.02 | +£0 | |
| Yr 11 Profit from sales | £0 | +£0 | |
| Yr 11 proj avg monthly profit | -£7.69 | (-0.1%) | +£0.96 |
| Total Dividends | £12,488.07 | +£0 | |
| Total Interest | £8.59 | +£0 | |
| Total Profit from sales | £17,560.27 | +£0 | |
| Average monthly cash profit | £241.44 | (3.3%) | -£0.46 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits went up £74 thanks to BOKU:Boku and total value went up a healthy £1,691. Year 11 performance should go positive in 2 weeks when a CAPD:Capital dividend comes through, but meantime is negative due to ISA fees.
Will it last more than a week?
Still below the trend line.
The SIPP looks like this after week 513 overall and week 45 of year 10.
| Weekly Change | ||||
| Cash | £1,642.70 | -£27.64 | ||
| Portfolio cost | £137,470.05 | +£239.26 | ||
| Portfolio sell value (bid price - commission) | £73,155.64 | (-46.8%) | +£2,314.24 | |
| Potential profits | £6,800.20 | +£281.04 | ||
| Yr 10 Dividends | £1,658.24 | +£91.24 | ||
| Yr 10 Interest | £4.00 | +£0 | ||
| Yr 10 Profit from sales | £6,948.31 | +£57.88 | ||
| Yr 10 proj avg monthly profit | £809.90 | (10.9%) | -£3.72 | |
| Total Dividends | £17,774.89 | +£91.24 | ||
| Total Interest | £16.90 | +£0 | ||
| Total Profit from sales | £23,956.25 | +£57.88 | ||
| Average monthly cash profit | £339.29 | (4.5%) | +£0.60 |
I sold my CAPD:Capital shares as they have fallen out of my top 50 in the magic formula and they had a brief spike in mid-week to allow me to take a profit. I sold 1,123 shares at 104.1p making £57.88 (5.2%) profit, or 7% if you include the £21 dividend, with another dividend still to come.
I bought 127 shares in KNOS:Kainos Group at 878.7p costing £1,133.48. They went up 1% after I bought them, but are 1% down due to commission. They are 9th on my magic formula ranking, but I had avoided them due to a long decline in share price. However they recently surged so seem to have some upward momentum. They pay a 3.87% dividend, have ROI of 20.79%, debt to equity of 4.03% and 5-year earnings per share growth of 13.31%. I now have 18 of my top 30 ranking shares, with 9 on my watch list and 3 written off for ethical or red flag reasons.
I also got a tax rebate in my AJ Bell account, so once again bought some more JLP:Jubilee Metals shares. I bought 6,584 at 3.0375p costing £204.99.
I also got a tax rebate in my AJ Bell account, so once again bought some more JLP:Jubilee Metals shares. I bought 6,584 at 3.0375p costing £204.99.
I had a £21 dividend from ARBB:Arbuthnot Banking, £43 from RIO:Rio Tinto, and £26 from SBRE:Sabre Insurance.
Year 10 performance remains above 10% with just 7 weeks of the year left to go, but long term profit remained flat at 4.5%, which is unchanged since the beginning of year 10, mainly because the cost of the portfolio has gone up quite a lot with regular injections.
I just can't close the gap to the injection line.
As with the ISA, still below the trend line
Trend line still upwards and we're above it.
Both JLP:Jubilee Metals and OPTI:Optibiotix are due an update in the next few weeks. JLP on copper production and progress on selling the South African operation, and OPTI on 2nd generation products. Seed Health have put out a teaser that they're launching something on 30th September. Could it possibly be the first product to contain Sweetbiotix? Probably not given the serial disappointment we're going through at the moment. It's nice to dream though.
I just can't close the gap to the injection line.
As with the ISA, still below the trend line
Trend line still upwards and we're above it.
Both JLP:Jubilee Metals and OPTI:Optibiotix are due an update in the next few weeks. JLP on copper production and progress on selling the South African operation, and OPTI on 2nd generation products. Seed Health have put out a teaser that they're launching something on 30th September. Could it possibly be the first product to contain Sweetbiotix? Probably not given the serial disappointment we're going through at the moment. It's nice to dream though.
No comments:
Post a Comment